1 - Now we'll see if AbbVie has the string pulling abilities of Gilead ... I doubt it.
3 - Okay, makes sense now.
2 - Hmmm. Getting a combination approved for treatment without the use of an NS5B has to mean that:
a - That's got to be some damn good medicine ....
b - It's got to make Gilead nervous ....
c - There should be some downward price pressure on NS5Bs ...
Edit: Especially seeing as it's only an 8 week treatment!
I suspect that any doctor working within the financial constraints of health insurance plans or government funded programs will prescribe it that way if it's approved that way .... but ...
I have a difficult time believing that any doctor prescribing generics to people who can/will self-pay would forgo the extra help of an NS5B.
Edit: Or prescribing for only 8 weeks.
Am I right?
Side note: Look up one post, on the right side, in the gray bar.
Voxilaprevir (akaGS-9857) - A new Protease Inhibitor
6 years 2 months ago #25011